newsfilter
← Latest News
GlobeNewswire·

Talaris Therapeutics to Participate at Two Upcoming Virtual Investor Conferences

BOSTON and LOUISVILLE, Ky., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (NASDAQ:TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation